Erlotinib Tablets

Solicitation75N91020Q00004Notice typeAward Notice

Attachments

0 files

No attachments available.

Version History

Erlotinib Tablets

Award75N91020Q00004Jan 27, 2020 · v5

Latest

Brand Name or Equal Tarceva (erlotinib hydrochloride) Tablets

Combined Synopsis75N91020Q00004Jan 10, 2020 · v4

Viewing

Brand Name or Equal Tarceva (erlotinib hydrochloride) Tablets

Award75N91020Q00004Jan 27, 2020 · v2

Opportunity Summary

The National Institutes of Health, through the NIH National Cancer Institute, issued an award notice for the procurement of Erlotinib tablets under solicitation number 75N91020Q00004. This requirement is categorized under NAICS 325412 Pharmaceutical Preparation Manufacturing and PSC 6505 Drugs and Biologicals. The action was designated as an SBA; SBA set-aside.

The place of performance for this contract is in the USA. The notice was published and last updated on January 27, 2020, with no associated attachments. Adam Hernandez is the designated point of contact for this award.

Generated by Lumen AI

Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.

Opportunity Summary

Opportunity Details

Response deadline: —No deadline provided
NAICS: 325412 (opens in new tab)
PSC: 6505 (opens in new tab)
Set aside: SBA
Published: Jan 27, 2020
Updated: Jan 27, 2020
Agency: NATIONAL INSTITUTES OF HEALTH (opens in new tab)
Office: NIH National Cancer Institute
Department: —
Source: View on SAM.gov (opens in new tab)

Contact and place of performance

Point of contact: Adam Hernandez

Place of performance: USA

Original Description

No narrative description provided for this notice.

NAICS 325412 award landscapeCompare incumbent and competitor award activity

Open PSC 6505 opportunitiesTrack solicitations in this service category

PSC 6505 contractsReview related contracts in this category

Opportunity Summary

The National Institutes of Health, through the NIH National Cancer Institute, issued an award notice for the procurement of Erlotinib tablets under solicitation number 75N91020Q00004. This requirement is categorized under NAICS 325412 Pharmaceutical Preparation Manufacturing and PSC 6505 Drugs and Biologicals. The action was designated as an SBA; SBA set-aside.

The place of performance for this contract is in the USA. The notice was published and last updated on January 27, 2020, with no associated attachments. Adam Hernandez is the designated point of contact for this award.

Generated by Lumen AI

Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.